Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-30-22 | Sep-05-22 | Sep-30-21 | Sep-05-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| Medical Device | 72.4 | | 78.3 | | 71.4 | 78.4 | 60.5 | 54.0 |
| Royalties | 36.2 | | 47.1 | | 40.6 | 48.5 | 35.4 | 31.8 |
| In Vitro Diagnostics | 27.6 | | 26.9 | | 23.5 | 21.7 | 20.8 | 19.1 |
| Abbott | | | | | | | 8.9 | |
| |
| EBITDA |
| Medical Device | -14.6 | | 11.9 | | 3.0 | 10.6 | -3.1 | 11.4 |
| In Vitro Diagnostics | 13.4 | | 14.2 | | 12.3 | 11.1 | 9.0 | 8.7 |
| |
| EBIT |
| Medical Device | -22.9 | | 4.7 | | -3.2 | 4.8 | -8.5 | 6.9 |
| In Vitro Diagnostics | 13.1 | | 13.8 | | 11.8 | 10.6 | 8.6 | 8.3 |
| |
| Mix |
| Medical Device | 72.4% | | 74.4% | | 75.3% | 78.3% | 74.4% | 73.8% |
| Royalties | 36.3% | | 44.8% | | 42.8% | 48.4% | 43.6% | 43.5% |
| In Vitro Diagnostics | 27.6% | | 25.6% | | 24.7% | 21.7% | 25.6% | 26.2% |
| Abbott | | | | | | | 11.0% | |
| |
| Growth |
| Medical Device | -7.5% | | 9.6% | | -8.9% | 29.5% | 12.1% | 1.5% |
| Royalties | -23.0% | | 15.8% | | -16.1% | 36.8% | 11.4% | |
| In Vitro Diagnostics | 2.5% | | 14.6% | | 8.0% | 4.3% | 8.9% | 5.3% |
|